Sort
10,766 grants matching “checkpoint inhibitor”
The Memorial Sloan Kettering Cancer Center SPORE in Pancreas Cancer
$2,281,895Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
$2,281,096Song Yao · Roswell Park Cancer Institute Corp · UH3 · FY2024 · CA
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma
$2,278,344Laura Beretta · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
$2,275,719Scott Kopetz · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
SPORE in Gastrointestinal Cancers
$2,273,000Alison P Klein · Johns Hopkins University · P50 · FY2021 · CA
Mayo Clinic Breast Cancer SPORE
$2,272,470Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2019 · CA
Preclinical drug development in pancreatic cancer
$2,272,436Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Immunotherapy of low grade lymphoid malignancies
$2,271,399Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Epigenetic Therapies - New Approaches
$2,269,729Jean-Pierre J Issa · Coriell Institute For Medical Research · P50 · FY2021 · CA
Genes and signals controlling mammalian hematopoiesis.
$2,266,693Paul E Love · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
$2,266,220Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2024 · CA
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant
$2,264,107Alan David D'andrea · Dana-Farber Cancer Inst · P50 · FY2021 · CA
SPORE in Skin Cancer
$2,257,242Meenhard Herlyn · Wistar Institute · P50 · FY2024 · CA
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
$2,256,456Barbara Burtness · Yale University · P50 · FY2021 · DE
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases
$2,252,657Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
SPORE: Targeted Therapies for Glioma
$2,252,175Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2021 · CA
Conserved Element DNA Vaccine
$2,251,746Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
$2,250,699David A Barbie · Dana-Farber Cancer Inst · P50 · FY2025 · CA
HCC Ovarian Cancer SPORE
$2,250,657Ronald J Buckanovich · University Of Pittsburgh At Pittsburgh · P50 · FY2025 · CA
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
$2,250,220David A Barbie · Dana-Farber Cancer Inst · P50 · FY2024 · CA
SPORE: Targeted Therapies for Glioma
$2,250,039Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2022 · CA
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$2,245,745Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant
$2,245,572Alan David D'andrea · Dana-Farber Cancer Inst · P50 · FY2023 · CA
University of Texas Southwestern Medical Center SPORE in Kidney Cancer
$2,243,520James Brugarolas · Ut Southwestern Medical Center · P50 · FY2024 · CA
Next generation T cell therapies for mutant KRAS solid tumors
$2,238,704Beatriz M. Carreno · University Of Pennsylvania · UH3 · FY2025 · CA